| cell line | treatment | results |
---|---|---|---|
receptor expression | LNCaP |  | ER-α + ER-β + |
 | PC-3 |  | ER-α 0 ER-β 0 |
clonogenic survival | LNCaP | genistein | survival reduced |
 |  | estradiol | survival increased (0.01 μM)/no effect (higher concentrations) |
 |  | genistein + RT | area of HRS enlarged |
 |  | estradiol + RT | area of HRS enlarged |
 | PC-3 | genistein | survival reduced |
 |  | estradiol | survival increased (0.01 μM)/no effect (higher concentrations) |
 |  | genistein + RT | HRS abolished |
 |  | estradiol + RT | HRS abolished |
p21 expression | LNCaP | RT | increased expression |
 |  | RT + genistein 10 μM | reduced expression |
 |  | RT + estradiol 10 μM | reduced expression |
 | PC-3 |  | no expression |
FACS (cell cycle) | LNCaP | controls | G0/G1 arrest |
 |  | genistein or estradiol | G0/G1 arrest |
 |  | RT | G0/G1 arrest |
 | PC-3 | genistein or estradiol | no influence |
 |  | RT | G2/M arrest |
 |  | RT + genistein or estradiol | G2/M arrest reduced |